Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Saeedeh Ghorbanalipoor; Shirin Emtenani; Melissa Parker; Mayumi Kamaguchi; Colin Osterloh; Manuela Pigors; Natalie Gross; Stanislav Khil'chenko; Anika Kasprick; Sabrina Patzelt; Diana Wortmann; Ibrahim O Ibrahim; Kentaro Izumi; Stephanie Goletz; Katharina Boch; Kathrin Kalies; Katja Bieber; Paul Smith; Enno Schmidt; Ralf J Ludwig

doi:10.3389/fimmu.2022.1099535

Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

Front Immunol. 2022 Nov 30:13:1099535. doi: 10.3389/fimmu.2022.1099535. eCollection 2022.

Authors

Saeedeh Ghorbanalipoor¹, Shirin Emtenani¹, Melissa Parker², Mayumi Kamaguchi¹, Colin Osterloh¹, Manuela Pigors¹, Natalie Gross¹, Stanislav Khil'chenko¹, Anika Kasprick¹, Sabrina Patzelt¹, Diana Wortmann¹, Ibrahim O Ibrahim¹, Kentaro Izumi¹, Stephanie Goletz¹, Katharina Boch³, Kathrin Kalies⁴, Katja Bieber¹, Paul Smith², Enno Schmidt¹, Ralf J Ludwig¹

Affiliations

¹ Lübeck Institute of Experimental Dermatology and Center for Research on Inflammation of the Skin, University of Lübeck, Lübeck, Germany.
² Incyte Research Institute, Wilmington, DE, United States.
³ Department of Dermatology, University of Lübeck, Lübeck, Germany.
⁴ Institute of Anatomy, University of Lübeck, Lübeck, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.865241.].

Keywords: animal model; autoimmunity; epidermolysis bullosa acquisita; mucous membrane pemphigoid; neutrophils; pemphigoid; phosphatidylinositol 3-kinase (P13k); signal transduction.

Copyright © 2022 Ghorbanalipoor, Emtenani, Parker, Kamaguchi, Osterloh, Pigors, Gross, Khil’chenko, Kasprick, Patzelt, Wortmann, Ibrahim, Izumi, Goletz, Boch, Kalies, Bieber, Smith, Schmidt and Ludwig.

Publication types

Published Erratum